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Segmentation error in spectral domain
optical coherence tomography measures of
the retinal nerve fibre layer thickness in
idiopathic intracranial hypertension
Anuriti Aojula1,2†, Susan P Mollan1,3*†, John Horsburgh3, Andreas Yiangou1,2,5, Kiera A Markey1,2,5,
James L Mitchell1,2,5, William J Scotton1,2,5, Pearse A Keane4 and Alexandra J Sinclair1,2,5
Abstract
Background: Optical Coherence Tomography (OCT) imaging is being increasingly used in clinical practice for
the monitoring of papilloedema. The aim is to characterise the extent and location of the Retinal Nerve Fibre
Layer (RNFL) Thickness automated segmentation error (SegE) by manual refinement, in a cohort of Idiopathic
Intracranial Hypertension (IIH) patients with papilloedema and compare this to controls.
Methods: Baseline Spectral Domain OCT (SDOCT) scans from patients with IIH, and controls with no retinal
or optic nerve pathology, were examined. The internal limiting membrane and RNFL thickness of the most
severely affected eye was examined for SegE and re-segmented. Using ImageJ, the total area of the RNFL
thickness was calculated pre and post re-segmentation and the percentage change was determined. The
distribution of RNFL thickness error was qualitatively assessed.
Results: Significantly greater SegE (p = 0.009) was present in RNFL thickness total area, assessed using
ImageJ, in IIH patients (n = 46, 5% ± 0–58%) compared to controls (n = 14, 1% ± 0–6%). This was particularly
evident in moderate to severe optic disc swelling (n = 23, 10% ± 0–58%, p < 0.001). RNFL thickness was
unable to be quantified using SDOCT in patients with severe papilloedema.
Conclusions: SegE remain a concern for clinicians using SDOCT to monitor papilloedema in IIH, particularly
in the assessment of eyes with moderate to severe oedema. Systematic assessment and manual refinement
of SegE is therefore important to ensure the accuracy in longitudinal monitoring of patients.
Keywords: Papilloedema, Idiopathic intracranial hypertension, Pseudotumour Cerebri, Optical coherence tomography,
Retinal nerve fibre layer, Artefact, Imaging, Monitoring
Background
Quantifying papilloedema clinically is subjective and prone
to inter–observer variability and inaccuracy during
prospective monitoring [1]. Spectral Domain Optical
Coherence Tomography (SDOCT) is increasingly used
both in the clinical environment and as outcome mea-
sures in Idiopathic Intracranial Hypertension (IIH)
clinical trials to objectively quantify papilloedema [2].
Commercially available SD-OCT imaging systems,
such as the Cirrus HD-OCT (Carl Zeiss Meditec,
Dublin, CA) and Spectralis (Heidelberg Engineering,
Heidelberg, Germany), have proprietary in-built OCT
software logarithms which use the difference in signal
intensity between adjacent retinal layers to perform
automated segmentation to segment inner and outer
retinal boundaries, from which retinal nerve fibre
layer thickness (RNFL thickness) measurements can
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be calculated. Optic disc swelling can be monitored by
repeated assessments of the RNFL thickness [2–4].
Autosegmentation has been found to be inaccurate in
some retinal pathologies such as neovascular age related
macular degeneration and central serous retinopathy [5]
and in optic nerve head pathologies such as glaucoma [6].
In papilloedema, where the interface between the retinal
layers is disturbed by oedema, errors in autosegmentation
have been noted [7–9], with large studies using the Cirrus
HD-OCT. The aim of this study was to evaluate the extent
and location of the RNFL thickness SegE in an IIH cohort,




Fifty-two consecutive IIH patients with a mean age of
31 years (standard deviation (SD) 9.4 years) and 14 controls
with a mean age of 35.9 years (SD 7.21 years) at University
Hospitals Birmingham NHS Foundation Trust (UHB NHS
FT), a large tertiary referral centre, were enrolled. All par-
ticipants were female. The study followed the tenets of the
Declaration of Helsinki; informed consent was obtained;
and the research was approved as a service evaluation by
the UHB NHS FT research and development department.
For inclusion, subjects were required to have active disease
(papilloedema with at least Frisén grade 1 in one eye) and
fulfil the accepted revised diagnostic for IIH [10]. The IIH
cohort had a median body mass index (BMI) of 38.7kgm−2
(range 24.3–51.3kgm−2) and a median baseline lumbar
puncture opening pressure (LP OP) of 35.5 cm CSF
(25.0–60.0 cm CSF). Using the Modified Frisén Scale
[11], two independent reviewers (SPM and JH) strati-
fied anonymised fundal photos according to the degree
of papilloedema; 23 were classified as mild disc swelling
(Frisén grade 1–2), and 29 with moderate/severe disc
swelling (Frisén grade 3–5). Healthy control subjects
were recruited only after retinal and/or optic nerve
pathology was excluded. Lumbar punctures and BMI
indices were not conducted in the control group.
SDOCT imaging
SDOCT RNFL thickness peripapillary circular scans were
acquired from all subjects using Heidelberg Engineering
SPECTRALIS HRA + OCT (Heidelberg Engineering,
Heidelberg, Germany). Spectralis OCT uses a dual-beam
SDOCT, a confocal laser-scanning ophthalmoscope with a
wavelength of 870 nm, and an infrared reference image to
obtain images of ocular microstructures with an acquisition
rate of 40,000 A-scans per second. Sufficient OCT scan
quality was considered as a Q score of greater than 12 and
the absence of posterior vitreous detachment, fovea mala-
lignment or media opacity secondary to cataract. The Spec-
tralis OCT software allows for automatic segmentation of
the upper and lower borders of the RNFL to calculate
the average RNFL thickness. Peripapillary RNFL thick-
ness values are divided into 4 quadrants, namely super-
ior, inferior, nasal and temporal. The SD-OCT scans
were qualitatively and quantitatively examined for
RNFL thickness SegE and analysed with both the Spec-
tralis automated software and then ImageJ Software
package (https://imagej.nih.gov/ij/).
Examination for OCT segmentation error (SegE)
A masked reviewer (AA) assessed anonymised OCT scans
for SegE using Heidelberg Eye Explorer software, version
1.9.1. (Heidelberg Engineering, Heidelberg, Germany). For
each subject, only one eye was analysed using the baseline
OCT scan from the most severely affected eye; this was
identified by the highest single point maximum RNFL
thickness value (μm). Initially the SegE was qualitatively
assessed and the location recorded. Quantitative analysis
then involved evaluating the internal limiting membrane
and RNFL thickness for the presence of SegE and accord-
ingly using the Heidelberg Eye Explorer software which
automatically identifies the layer border and allows for
manual correction of the segmentation. Pre- and post
re-segmentation, average and maximum height of the
RNFL thickness (μm) was recorded in the following
areas: global RNFL thickness and the superior, nasal,
inferior and temporal retinal quadrant. Finally, pre and
post re-segmentation, the RNFL thickness total area
was delineated and quantified independently of the
Heidelberg Eye Explorer software, using the ImageJ
software polygon and analyse area tool, respectively.
The percentage change in the total area of the RNFL
area was subsequently calculated. Quality assurance was
undertaken with a further masked observer (JH) independ-
ently examining SegE in a quarter (n = 20) of the subjects
in the cohort to ensure there was sufficient concordance.
Statistics
Descriptive statistics were used to compare demographic
characteristics by group (IIH and healthy controls). Statis-
tical analysis was performed using SPSS software, version
23.0 (IBM, Armonk, NY). Due to the lack of normal distri-
bution, data were analysed using the Kruskal-Wallis test
and tested for significant pairwise comparisons. Values were
expressed as the median ±range. A two-tailed Spearman’s
correlation test was used to conduct correlation analysis.
Values were deemed statistically significant at p < 0.05.
Results
Of the 52 IIH patients, the scans from 6 patients were
excluded as they had such severe papilloedema that the
optic nerve head elevation was truncated by the scan
image and therefore the height could not be visualised
and no further accurate refinement of the RNFL thickness
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could be performed. Forty-six IIH subjects and 14
controls were therefore included in the quantitative
analysis (Fig. 1). The reliability between the two inde-
pendent raters (AA and JH) was 0.732, with 95% CI
(0.232–0.926), p < 0.05.
Quantification of the difference between the auto-
mated and the manually corrected total RNFL thickness
area using ImageJ revealed significantly greater SegE in
IIH patients [5% change post segmentation refinement,
range = 0–58%] compared to controls [1% change post
segmentation refinement, range = 0–6%] p = 0.009 (Table 1;
Additional file 1: Table S1, S2). This was particularly evi-
dent in IIH patients with moderate to severe papilloedema
[10% change post segmentation refinement, range = 0–58%,
p < 0.001]. (Additional file 1: Table S3).
The error in automated overall average RNFL thickness
values was significantly greater in IIH compared to
controls (p = 0.031): median176μm (range 76-581 μm) pre
re-segmentation versus 159 μm (range 83-391 μm) post
re-segmentation in IIH (4% change post re-segmentation,
range 0–58%) this was compared to 98 μm (range 63-
125 μm) pre segmentation versus 100 μm (range 65-
126 μm) post re-segmentation in controls (2% change post
re-segmentation, range = 0–6%). IIH patients with moder-
ate to severe papilloedema displayed significantly greater
error in the overall average RNFL thickness values
compared to those with mild papilloedema [10% change
post re-segmentation (range 0–58% in moderate and
severe papilloedema, p = 0.002)] (Table 1 and Fig. 2). In
those with moderate to severe papilloedema the SegE
was significantly greater in the superior retinal quadrant
[11% change post re-segmentation, range = 0–375%,
p = 0.001] (Fig. 3).
Qualitative assessment of any error in the RNFL thick-
ness segmentation was more often identified in IIH (any
apparent error in 98% of the IIH group, (45/46)) com-
pared to control subjects (error in 79% of patients,
(11/14)) (Table 2). It was clearly observed that the
magnitude of the SegE was more pronounced in the
IIH compared to control subjects. There was no clear
pattern between subjects of whether the error was in-
flation or deflation of their disc height. In IIH patients,
the RNFL thickness SegE was predominantly noted in
the superior retinal quadrant, but to a lesser degree in
the inferior retinal quadrant. In contrast, the control
subjects displayed minimal error that had no predom-
inant distribution.
The highest single point of maximum thickness in the
RNFL thickness was then assessed and there was no statis-
tically significant difference in RNFL thickness segmenta-
tion between the automated and the manually corrected
segmentation between IIH and controls. However error in
the maximal height in the superior region in those with
moderate or severe papilledema did have significant error
pre- and post re-segmentation in the superior retinal
quadrant: 345 μm (range 139-1007 μm) automated value
versus 297 μm (range 178-445 μm) post re-segmentation
(12% change post re-segmentation, range = 0–60%,
p = 0.017), compared to 174 μm (range 144 - 211 μm)
automated values and 184 μm (range 150–211 μm)
post re-segmentation for the controls (3% change post
re-segmentation, range = 0–26%).
Fig. 1 This is showing the consort pathway for inclusion and exclusion of subjects in this study
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Discussion
OCT imaging is increasingly utilised for quantification and
monitoring of papilloedema in IIH in the clinical setting.
The largest prospective controlled cohort in papillodema
reporting use of OCT in IIH is data from the IIHTT [2];
this study investigated 126 participants and utilised the
Cirrus OCT at multiple centres and found that 3-
dimensional scanning was less prone to failures of seg-
mentation than 2-dimensional images. There is limited
literature on the accuracy of autosegmentation in papilloe-
dema using the Spectralis OCT. Detection of SegE, and
manually refining the interfaces could help improve the
accuracy of the RNFL thickness values between consecu-
tive tests, and improve the clinical utility of the SD-OCT
in longitudinal monitoring of IIH. This study highlights
the issue of significant error in the automated RNFL thick-
ness values generated from peripapillary RNFL thickness
circle scans using the Spectralis SD-OCT. Like other SD
OCT devices, the Spectralis in built algorithms are not
specifically designed to autosegment papilloedema and
although we identified significant error in the overall aver-
age RNFL thickness value with a 4% change following
Table 1 Qualitative assessment of the distribution of RNFL thickness segmentation error comparing the IIH and control cohorts
using median values and ranges
Location Overall IIH % error
(n = 46)
Mild IIH % error
(n = 23)
Moderate-severe
IIH % error (n = 23)
Control % error
(n = 14)
p overall p moderate-severe
Using ImageJ
Total area of RNFL 5 (0–58) 2 (0–16) 10 (0–58) 1 (0–6) 0.009a <0.001a
Using spectalis automated software
Average
Overall 4 (0–58) 2 (0–16) 10 (0–58) 2 (0–6) 0.031a 0.002a
Superior 8 (0–375) 6 (0–115) 11 (0–375) 3 (0–10) 0.007a 0.001a
Nasal 2 (0–81) 2 (0–30) 1 (0–81) 1 (0–14) NS NS
Inferior 4 (0–79) 3 (0–12) 6 (0–79) 2 (0–11) 0.031a 0.008a
Maximum
Highest Single Point 5 (0–62) 5 (0–43) 7 (0–62) 4 (0–14) NS NS
Superior 7 (0–60) 5 (0–42) 12 (0–60) 3 (0–26) 0.044a 0.017a
Nasal 6 (0–70) 5 (0–51) 8 (0–70) 7 (0–133) NS NS
Inferior 5 (0–96) 3 (0–114) 7 (0–96) 3 (0–17) NS 0.049a
Temporal 3 (0–43) 3 (0–21) 3 (0–43) 1 (0–28) NS NS
NB values are compared with the control group. There were no significant differences in mild disc swelling for any of the above parameters. NS not significant;
aindicates statistical significance
Fig. 2 Demonstrates the typical infra-red (IR) images pre and post refinement of the automated segmentation. 1a-1c is a case of mild disc swelling: 1a, IR
image of optic nerve head; 1b, Cross section of the peripapillary RNFL scan as autosegmented; 1c, Cross section of the peripapillary RNFL scan following
refinement of the segmentation manually. 1d-1f is a case of moderate to severe disc swelling: 1d, IR image of optic nerve head; 1e, Cross section of the
peripapillary RNFL scan as autosegmented; 1f, Cross section of the peripapillary RNFL scan following refinement of the segmentation manually
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manual re-segmentation, this is much less error than pre-
viously reported using time domain OCT platforms [12].
What is yet to be determined is the clinical significance of
the magnitude of this error.
The SegE was most apparent in those with moderate
to severe papilloedema (10% error) and particularly in the
superior retinal quadrant (11% error). The majority of the
RNFL thickness error was accounted for by inaccurate au-
tomated identification of the lower boarder of the RNFL
at the junction with the ganglion cell layer. It is likely that
oedema and vessel artefact lead to error in the average
RNFL thickness automated values, as postulated by previ-
ous authors [9, 13].
In 6% of the cohort, with severe papilloedema, the
extreme elevation of the optic nerve head obscured the
upper boarder limit of the RNFL and it was therefore
not possible to refine the segmentation in these patients
due to the truncation of the image. This truncation arte-
fact has been previously reported by other authors [the
type 1–8 paper] [9]. It may be less of an issue with
newer OCT systems, using swept source technology, that
provide a greater depth of imaging (e.g., Topcon DRI
OCT-1 Triton has a depth range of 2.6 mm – greater
than the 1.9 mm depth range of the Heidelberg system,
based on spectral domain technology) [14].
Fig. 3 This figure presents the IR image of the optic nerve head and the cross-sectional peripapillary circle scan for three subjects (ab, cd, ef). The
figure demonstrates that in moderate to severe optic nerve head swelling the RNFL boundary as delineated by autosegmentation (blue line) is
variable and not accurate. The average RNFL thickness values in these cases will be very inaccurate in these patients. In subject CD the height of
the elevation of the optic nerve head is truncated by the image width and hence any values obtained from this scan are inaccurate. All the cases
presented in these images were not manually segmented and were excluded from the study
Table 2 Qualitative assessment of the distribution of RNFL
thickness segmentation error
Error location IIH (n = 46) Control (n = 14)
No error seen 1 3
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SegE is not the only cause for erroneous RNFL thickness
values; a number of factors have been associated with arti-
facts in OCT scanning including decentration error,
refractive error, posterior vitreous detachment arti-
facts, reduced visual acuity, small pupils, presence of
media opacities, advanced stage of glaucoma and dry
eyes [9, 15–18] Eye tracking on Spectralis ensures better
alignment and is reported to decreases error in malalign-
ment [19, 20].
Manual refinement of segmentation has several limita-
tions which include the time taken to perform this ac-
curately; indeed the accuracy of the manual markings, in
which experts invariably disagree on where to draw the
margins when the boarders between layers are hazy. In
this study we performed an inter-user variability check
to ensure that there was sufficient agreement between
two masked individuals. The clinical impact of this error
has not been evaluated in this study but would be a use-
ful area for future investigation. As the Spectralis SD
OCT platform was used in this study our results may
not be generalizable to results from other types of SD-
OCT machines.
RNFL thickness peripapillary scans are not the only
OCT scan modality used to assess papilloedema. Other
scanning modalities include volumetric analysis of the
optic nerve head and macula; and Bruchs Membrane
Opening (BMO) rim analysis. However, the degree of
oedema in moderate to severe papilloedema is also
known to cause error in these scans due to optical pene-
tration. Future solutions include better depth penetra-
tion and a wider scan window to account for the
elevation found in disc oedema. Polarization-sensitive
OCT, which is not currently commercially available,
has the potential to delineate the RNFL boundary better
based on pigment differences in the retinal layers and
be less prone to SegE [21].
In the setting of virtual IIH clinics where patient’s
management may be judged exclusively by objective
OCT and Humphrey visual field values; there could be
clinical risk in the misinterpretation of the degree of
papilledema and its course over time if the SegE is not
identified and corrected for at the time of acquisition
of the scans [9]. Here we have highlighted the limitations
of using automated results from OCT RNFL thickness
scans, particularly in those with marked papilloedema. We
have developed a suggested paradigm to guide healthcare
professionals performing OCT RNFL thickness peripapil-
lary scans in IIH (Fig. 4). Scans should be evaluated for
error at the time of acquisition to ensure the accuracy of
the data at the time of the clinical visit when management
decisions may be being made. However, as demonstrated
with the results from the IIHTT [2] we would recommend
the use of optic nerve volume scans in the routine clinical
assessment of papilloedema.
Conclusions
Using the Spectralis SD-OCT, SegE in RNFL thickness
values were found to be greater in IIH than controls,
with the error increasing with the severity of the papil-
loedema. Imaging was not useful in very severe papil-
loedema where the image was truncated. This is the
largest cohort assessing SegE in IIH, using the Spec-
tralis SD-OCT. Achieving accurate and reproducible
image analysis is important in the longitudinal moni-
toring in IIH, hence recognition of SegE and manual
refinement should be understood by technicians and
clinicians alike.
Additional file
Additional file 1: Table S1. IIH Cohort showing absolute median
values (range) pre and post segmentation with % change. Table S2.
Controls showing absolute median values (range) pre and post segmentation
with % change. Table S3. Moderate to severe IIH showing absolute median
values (range) pre and post segmentation with % change. Table S4. Mild IIH
showing absolute median values (range) pre and post segmentation with %
change. (DOCX 35 kb)
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Fig. 4 Practical Algorithm for inclusion of SD-OCT RNFL thickness
values in the clinical setting
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